Roberts Zachary 4
4 · Allogene Therapeutics, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
Roberts Zachary
EVP of R&D
Transactions
- Award
Stock Option (Right to buy)
2024-01-25+494,949→ 494,949 totalExercise: $3.20Exp: 2034-01-25→ Common Stock (494,949 underlying) - Award
Common Stock
2024-01-25+140,000→ 515,253 total
Footnotes (1)
- [F1]1/3 of the shares subject to the stock option shall vest on January 25, 2025, and the remaining shares shall vest in 24 equal monthly installments thereafter.